Sarah Dunsmore, Ph.D., is a program director in the NIGMS Division of Pharmacology, Physiology, and Biological Chemistry, where she oversees research grants in the areas of receptors, drug targets and signal transduction; sepsis and innate immunity; and inflammation and mentored career development awards in the areas of sepsis, drug targets and innate immunity. She serves as the program director for several clinical trials testing novel treatments for sepsis and septic shock.
Prior to joining NIGMS in 2006, Dunsmore was a faculty member at Harvard Medical School and conducted pulmonary research in a laboratory based at Brigham and Women’s Hospital in Boston, MA.
Dunsmore is the media contact for sepsis.
To arrange an interview with her, contact the NIGMS Office of Communications and Public Liaison at 301-496-7301.
For all other inquiries, send e-mail to email@example.com or call 301-594-3827.